Fostering program required for domestically developed new drugs.

4 new drugs have been developed by purely domestic research and development sources in Korea, but the rigid NHI pricing policy, taking too long period of its approval and price determination, has played as a serious barrier to the market release.

Moreover the medical communities did not pay any attention to such domestically developed new drugs. All in all, therefore, a certain fostering p...